Anti-beta2-Glycoprotein I Control
- UID
- IMP/IVD/2022/000088_d05119f1037938dacad337429117f779_0f5cc18ccb11e122848e77feec22374a
- Device class
- Class B
- Brand name
- IAA Control
- License holder
- M/s. CPC Diagnostics Pvt Ltd
- Approving authority
- CDSCO
- Product information
- The Anti-beta2-Glycoprotein I Control is intended for use as an assayed quality control sample to monitor the performance of the immunoassays for Anti-β2-Glycoprotein I on the iFlash systems.
Anti-beta2-Glycoprotein I Control is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000088_d05119f1037938dacad337429117f779_0f5cc18ccb11e122848e77feec22374a. This device is marketed under the brand name IAA Control. The license holder is M/s. CPC Diagnostics Pvt Ltd, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.